474 related articles for article (PubMed ID: 26634305)
21. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits.
Whitehead SJ; French J; Brookes MJ; Ford C; Gama R
Ann Clin Biochem; 2013 Jan; 50(Pt 1):53-61. PubMed ID: 23129721
[TBL] [Abstract][Full Text] [Related]
22. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
Puolanne AM; Kolho KL; Alfthan H; Ristimäki A; Mustonen H; Färkkilä M
Eur J Clin Invest; 2016 Oct; 46(10):825-32. PubMed ID: 27438629
[TBL] [Abstract][Full Text] [Related]
23. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.
Zhulina Y; Cao Y; Amcoff K; Carlson M; Tysk C; Halfvarson J
Aliment Pharmacol Ther; 2016 Sep; 44(5):495-504. PubMed ID: 27402063
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
[TBL] [Abstract][Full Text] [Related]
25. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
Coorevits L; Baert FJ; Vanpoucke HJ
Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
[TBL] [Abstract][Full Text] [Related]
26. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
27. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
28. Immunoanalytical characteristics of fecal calprotectin.
Desbène C; Gaillard O; Kapel N
Ann Biol Clin (Paris); 2016 Dec; 74(6):725-734. PubMed ID: 27848924
[TBL] [Abstract][Full Text] [Related]
29. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
Du L; Foshaug R; Huang VW; Kroeker KI; Dieleman LA; Halloran BP; Wong K; Fedorak RN
J Clin Gastroenterol; 2018 Mar; 52(3):235-240. PubMed ID: 28009684
[TBL] [Abstract][Full Text] [Related]
30. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
[TBL] [Abstract][Full Text] [Related]
31. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
[TBL] [Abstract][Full Text] [Related]
32. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
Kotze LM; Nisihara RM; Marion SB; Cavassani MF; Kotze PG
Arq Gastroenterol; 2015; 52(1):50-4. PubMed ID: 26017083
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
Delefortrie Q; Schatt P; Grimmelprez A; Gohy P; Deltour D; Collard G; Vankerkhoven P
Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
[TBL] [Abstract][Full Text] [Related]
34. Faecal calprotectin: a new marker for Crohn's disease?
Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
[TBL] [Abstract][Full Text] [Related]
35. Correlation between faecal calprotectin and magnetic resonance imaging (MRI) in the evaluation of inflammatory pattern in Crohn's disease.
Zippi M; Al Ansari N; Siliquini F; Severi C; Kagarmanova A; Maffia C; Parlanti S; Garbarino V; Maccioni F
Clin Ter; 2010; 161(2):e53-6. PubMed ID: 20499020
[TBL] [Abstract][Full Text] [Related]
36. Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease.
Aomatsu T; Imaeda H; Matsumoto K; Kimura E; Yoden A; Tamai H; Fujiyama Y; Mizoguchi E; Andoh A
Aliment Pharmacol Ther; 2011 Oct; 34(8):941-8. PubMed ID: 21848856
[TBL] [Abstract][Full Text] [Related]
37. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms.
Fagerberg UL; Lööf L; Myrdal U; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):450-5. PubMed ID: 15795593
[TBL] [Abstract][Full Text] [Related]
38. What is the faecal calprotectin test?
Drug Ther Bull; 2014 Sep; 52(9):102-4. PubMed ID: 25213590
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.
Kittanakom S; Shajib MS; Garvie K; Turner J; Brooks D; Odeh S; Issenman R; Chetty VT; Macri J; Khan WI
Can J Gastroenterol Hepatol; 2017; 2017():1450970. PubMed ID: 28491862
[No Abstract] [Full Text] [Related]
40. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]